|
VDAC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.07390000015207E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.35849999999471E-06 |
| Normal-vs-Stage2 |
3.46190000000135E-06 |
| Normal-vs-Stage3 |
1.899890E-03 |
| Normal-vs-Stage4 |
2.48979999999399E-05 |
| Stage1-vs-Stage2 |
1.011830E-02 |
| Stage1-vs-Stage3 |
4.059000E-01 |
| Stage1-vs-Stage4 |
1.914430E-01 |
| Stage2-vs-Stage3 |
3.956200E-03 |
| Stage2-vs-Stage4 |
1.545640E-01 |
| Stage3-vs-Stage4 |
6.309700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.03840000004385E-06 |
| Normal-vs-AfricanAmerican |
6.28459999999498E-05 |
| Normal-vs-Asian |
1.980600E-03 |
| Caucasian-vs-AfricanAmerican |
3.079600E-01 |
| Caucasian-vs-Asian |
8.764000E-01 |
| AfricanAmerican-vs-Asian |
3.914600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91169999999019E-05 |
| Normal-vs-Female |
1.52170000045082E-07 |
| Male-vs-Female |
8.079000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.25489999999828E-05 |
| Normal-vs-Age(41-60Yrs) |
2.04869999999024E-05 |
| Normal-vs-Age(61-80Yrs) |
8.85910000025802E-07 |
| Normal-vs-Age(81-100Yrs) |
1.124290E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.246800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.481200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.632400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.177570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.392000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.035000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.952000E-01 |
| Classical-VS-Follicular |
9.553000E-01 |
| Classical-VS-Other |
3.014400E-01 |
| Classical-VS-Normal |
3.20209999626897E-08 |
| Tall-VS-Follicular |
8.625000E-01 |
| Tall-VS-Other |
2.582800E-01 |
| Tall-VS-Normal |
4.357000E-04 |
| Follicular-VS-Other |
4.897600E-01 |
| Follicular-VS-Normal |
8.995900E-04 |
| Other-VS-Normal |
5.980200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.30569999999375E-05 |
| Normal-vs-N1 |
2.794000E-01 |
| N0-vs-N1 |
6.446300E-02 |
|
|
